Johnson & Johnson acquired Atraverse Medical. The deal expands J&J’s MedTech cardiovascular portfolio into high-growth medical device markets.
Atraverse specializes in transseptal access systems for minimally invasive cardiac procedures. The companies did not disclose financial terms.
Johnson & Johnson also partnered with Viz.ai. The collaboration integrates artificial intelligence into J&J’s neurovascular offerings.
Viz.ai provides AI-based imaging technology for stroke care. This technology offers data-driven clinical support to improve patient outcomes.